Jeil Pharma Holdings Inc (002620)

Currency in KRW
6,900
+20(+0.29%)
Closed·
Advertisement
002620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,8006,990
52 wk Range
6,0509,850
Key Statistics
Bid/Ask
6,820.00 / 6,960.00
Prev. Close
6,900
Open
6,880
Day's Range
6,800-6,990
52 wk Range
6,050-9,850
Volume
2.31K
Average Volume (3m)
4.45K
1-Year Change
-17.3653%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
14/08/2026
EPS / Forecast
-231.00 / --
Revenue / Forecast
164.7B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 549.45
Dividend Yield
1.02%
Industry Median 1.29%
Annualised payout
70.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 002620 to Peers and Sector

Metrics to compare
002620
Peers
Sector
Relationship
P/E Ratio
12.6x7.5x−0.3x
PEG Ratio
0.100.030.00
Price/Book
0.3x0.6x2.6x
Price / LTM Sales
0.2x0.4x2.9x
Upside (Analyst Target)
-67.5%64.0%
Fair Value Upside
Unlock23.4%9.7%Unlock

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Employees
41

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.50M9.75%10.54B
Public Companies & Retail Investors
13.85M90.25%97.53B
Total
15.35M100.00%108.07B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Otsuka Holdings Co., Ltd.9.75%1,497,05010,539,232

People Also Watch

7,120
007860
+2.45%
16,700
003300
-0.65%
35,550
001630
+0.28%
24,500
064960
+1.87%
52,100
025540
+0.77%

FAQ

What Is the Jeil Pharma Holdings (Seoul: 002620) Share Price Today?

The Jeil Pharma Holdings stock price today is 6,900 KRW.

What Stock Exchange Does Jeil Pharma Holdings (002620) Trade On?

Jeil Pharma Holdings is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Jeil Pharma Holdings?

The stock symbol (also called a 'ticker') for Jeil Pharma Holdings is "002620."

Does Jeil Pharma Holdings Pay Dividends? What’s The Current 002620 Dividend Yield?

Yes, 002620 Pays Dividends to its Shareholders. The current Jeil Pharma Holdings dividend yield is 1.0%%.

What Is the Current Jeil Pharma Holdings Market Capitalisation?

As of today, Jeil Pharma Holdings (Seoul: 002620) market cap is 105.92B KRW.

What Is Jeil Pharma Holdings's (002620) Earnings Per Share (TTM)?

The Jeil Pharma Holdings EPS is currently 549.45 (Trailing Twelve Months).

Is 002620 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Jeil Pharma Holdings moving averages and other technical indicators, the daily buy/sell signal for 002620 stock is Strong Sell.

How Many Times Has Jeil Pharma Holdings Stock Split?

Jeil Pharma Holdings has split 4 times. (See the 002620 stock split history page for full effective split date and price information.)

How Many Employees Does Jeil Pharma Holdings Have?

Jeil Pharma Holdings has 41 employees, based on their latest Companies House report.

What is the current trading status of Jeil Pharma Holdings (Seoul: 002620)?

As of 28/10/2026, Jeil Pharma Holdings (002620) is trading at a share price of 6,900 KRW, with a previous close of 6,900 KRW. The stock has fluctuated within a day range of 6,800 KRW to 6,990 KRW, while its 52-week range spans from 6,050 KRW to 9,850 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.